# Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The PATH III Trial)

> **NCT04448184** · PHASE3 · RECRUITING · sponsor: **Ottawa Hospital Research Institute** · enrollment: 662 (estimated)

## Conditions studied

- Hematologic Neoplasms

## Interventions

- **DRUG:** Tranexamic Acid

## Key facts

- **NCT ID:** NCT04448184
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-02-16
- **Primary completion:** 2027-02
- **Final completion:** 2027-02
- **Target enrollment:** 662 (ESTIMATED)
- **Last updated:** 2026-01-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04448184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04448184, "Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The PATH III Trial)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04448184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*